Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Tratamiento farmacologico

533 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Lemborexant: First Approval

Scott LJ.

Drugs. 2020 Mar;80(4):425-432. doi: 10.1007/s40265-020-01276-1.

0

0

0

PUBMED

Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues

Candasamy M, Mohamed Elhassan SA, Kumar Bhattamisra S, Hua WY, Sern LM, Binti Busthamin NA, Mohamad Ilni NB, Shun NS, Baohong L, Ya NS, Ying NW.

Panminerva Med. 2020 Sep;62(3):155-163. doi: 10.23736/S0031-0808.20.03879-3. Epub 2020 Mar 23.

0

0

0

PUBMED

Contribution of the Presenilins in the cell biology, structure and function of γ-secretase

Escamilla-Ayala A, Wouters R, Sannerud R, Annaert W.

Semin Cell Dev Biol. 2020 Sep;105:12-26. doi: 10.1016/j.semcdb.2020.02.005. Epub 2020 Mar 4.

0

0

0

PUBMED

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease

Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM.

Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858.

0

0

0

PUBMED

Takotsubo Cardiomyopathy in an Alzheimer Disease Patient: The Potential Contribution of Antidepressant Agents

Moulin Mares SRA, Groner JS, de Oliveira MP, Lírio LV, Coutinho PC, Luchi WM.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):360-361. doi: 10.1097/WAD.0000000000000395.

0

0

0

PUBMED

Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL.

J Geriatr Psychiatry Neurol. 2020 Jul;33(4):175-184. doi: 10.1177/0891988719874118. Epub 2019 Sep 23.

0

0

0

PUBMED

White Matter and Neuroprotection in Alzheimer's Dementia

Lorenzini L, Fernandez M, Baldassarro VA, Bighinati A, Giuliani A, Calzà L, Giardino L.

Molecules. 2020 Jan 23;25(3):503. doi: 10.3390/molecules25030503.

0

0

0

PUBMED

Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer's Disease

Sharma VK, Singh TG, Singh S.

Curr Drug Targets. 2020;21(13):1371-1384. doi: 10.2174/1389450121666200727104728.

0

0

0

PUBMED

Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease

Garcia-Leon JA, Caceres-Palomo L, Sanchez-Mejias E, Mejias-Ortega M, Nuñez-Diaz C, Fernandez-Valenzuela JJ, Sanchez-Varo R, Davila JC, Vitorica J, Gutierrez A.

Int J Mol Sci. 2020 Sep 18;21(18):6867. doi: 10.3390/ijms21186867.

0

0

0

PUBMED

Recent advances in tau-directed immunotherapy against Alzheimer's disease: an overview of pre-clinical and clinical development

Ng PY, Chang IS, Koh RY, Chye SM.

Metab Brain Dis. 2020 Oct;35(7):1049-1066. doi: 10.1007/s11011-020-00591-6. Epub 2020 Jul 6.

0

0

0

PUBMED

Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers

Bristol AA, Convery KA, Sotelo V, Schneider CE, Lin SY, Fletcher J, Rupper R, Galvin JE, Brody AA.

Contemp Clin Trials. 2020 Jun;93:106005. doi: 10.1016/j.cct.2020.106005. Epub 2020 Apr 19.

0

0

0

PUBMED

Insights from Drosophila melanogaster model of Alzheimer's disease

Tue NT, Dat TQ, Ly LL, Anh VD, Yoshida H.

Front Biosci (Landmark Ed). 2020 Jan 1;25(1):134-146. doi: 10.2741/4798.

0

0

0

PUBMED

Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool

Ha ZY, Mathew S, Yeong KY.

Curr Protein Pept Sci. 2020;21(1):99-109. doi: 10.2174/1389203720666191107094949.

0

0

0

PUBMED

Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells

Janitschke D, Lauer AA, Bachmann CM, Seyfried M, Grimm HS, Hartmann T, Grimm MOW.

Int J Mol Sci. 2020 Nov 27;21(23):9015. doi: 10.3390/ijms21239015.

0

0

0

PUBMED

Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases

Guo R, Li L, Su J, Li S, Duncan SE, Liu Z, Fan G.

Drug Des Devel Ther. 2020 Nov 5;14:4735-4748. doi: 10.2147/DDDT.S266911. eCollection 2020.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy